Literature DB >> 6974822

Asymptomatic coronary artery disease. Pathophysiology, diagnosis, management.

P F Cohn.   

Abstract

Entities:  

Mesh:

Year:  1981        PMID: 6974822

Source DB:  PubMed          Journal:  Mod Concepts Cardiovasc Dis        ISSN: 0026-7600


× No keyword cloud information.
  9 in total

Review 1.  Silent myocardial ischaemia. Implications for therapy.

Authors:  N G Uren; D P Lipkin
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

2.  Silent myocardial ischemia: a challenge for nuclear cardiologists.

Authors:  P F Cohn
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

Review 3.  Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

Authors:  M M Buckley; S M Grant; K L Goa; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 4.  Indications for treatment of silent myocardial ischemia.

Authors:  P F Cohn
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

Review 5.  [Significance of silent myocardial ischemia for identification and optimal therapy of patients with latent coronary heart disease. Is there a marker for prognostic indication for PTCA?].

Authors:  D Hering; H P Schultheiss; D Horstkotte
Journal:  Herz       Date:  1999-02       Impact factor: 1.443

6.  Vigorous exercise and cardiovascular death: a perspective.

Authors:  R J Northcote
Journal:  J R Soc Med       Date:  1985-11       Impact factor: 5.344

Review 7.  Prognostic value of myocardial perfusion imaging: state of the art and new developments.

Authors:  K A Brown
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

Review 8.  Silent ischemia: a relevant problem in patients with coronary artery disease?

Authors:  W Rutishauser; A Righetti; P Roy
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

Review 9.  Pain and the heart: discussion paper.

Authors:  L J Freeman; P G Nixon
Journal:  J R Soc Med       Date:  1988-02       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.